BRCA1 and lung carcinoma: RUNX2 is a coregulator of BRCA1 (Figure 2), the TF that regulates the LC-PAH CCP, strengthening the evidence that RUNX2 is associated with pulmonary arterial hypertension and lung cancer [12].